Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:SGEN

Seagen (SGEN) Stock Price, News & Analysis

Seagen logo

About Seagen Stock (NASDAQ:SGEN)

Advanced Chart

Key Stats

Today's Range
$228.74
$228.74
50-Day Range
$228.74
$228.74
52-Week Range
$123.77
$228.96
Volume
86 shs
Average Volume
1.48 million shs
Market Capitalization
$42.93 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive SGEN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Seagen and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

SGEN Stock News Headlines

Pfizer raises guidance as COVID franchise drives Q3 beat
New Banking Law #1582 Could Unlock $21 Trillion for Americans
Do you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. If you do…tc pixel
Franklin Biotechnology Discovery C
Pfizer: Turning The Corner (Rating Upgrade)
See More Headlines

SGEN Stock Analysis - Frequently Asked Questions

Seagen Inc. (NASDAQ:SGEN) issued its quarterly earnings results on Wednesday, November, 1st. The biotechnology company reported ($1.15) EPS for the quarter, missing the consensus estimate of ($0.82) by $0.33. The firm's revenue for the quarter was up 27.1% compared to the same quarter last year.

Seagen subsidiaries include Cascadian Therapeutics.

Based on aggregate information from My MarketBeat watchlists, some other companies that Seagen investors own include NVIDIA (NVDA), Meta Platforms (META), Intel (INTC), Tesla (TSLA), Advanced Micro Devices (AMD), Pfizer (PFE) and QUALCOMM (QCOM).

Company Calendar

Last Earnings
11/01/2023
Today
8/30/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biotechnology
Sub-Industry
Biotechnology
Current Symbol
NASDAQ:SGEN
CIK
1060736
Employees
3,256
Year Founded
1998

Profitability

EPS (Trailing Twelve Months)
($4.01)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$610.31 million
Net Margins
-32.61%
Pretax Margin
-32.12%
Return on Equity
-28.06%
Return on Assets
-20.92%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
2.67
Quick Ratio
2.12

Sales & Book Value

Annual Sales
$2.30 billion
Price / Sales
18.66
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$15.10 per share
Price / Book
15.15

Miscellaneous

Outstanding Shares
187,698,000
Free Float
139,084,000
Market Cap
$42.93 billion
Optionable
Optionable
Beta
0.32

Social Links

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

This page (NASDAQ:SGEN) was last updated on 8/30/2025 by MarketBeat.com Staff
From Our Partners